RWC-340B Applauds Newly Reformulated Senate 340B Bipartisan Working Group Bipartisan Working Group includes U.S. Senators Tammy Baldwin (D-Wis.), John Hickenlooper (D-Colo.), Tim Kaine (D-Va.), Shelley Moore Capito (R-W.V.), Jerry Moran…
RWC-340B Fact Sheet – Oppose 340B ACCESS Act
RWC-340B was asked to sign onto the attached letter to CMS commenting on its May 3, 2024 Draft Guidance implementing aspects of the Inflation Reduction Act (IRA). 340B Health drafted the…
RWC-340B carefully reviewed the draft legislation, explanatory statement, and supplemental request for information (RFI) that the Bipartisan 340B Senate Working Group (Working Group) shared with 340B stakeholders on February 2,…
RWC-340B welcomes the release of the bipartisan Senate Working Group on 340B’s legislative discussion draft of the “SUSTAIN 340B Act.” The draft bill – formally titled, the Supporting Underserved and Strengthening…
A growing number of pharmaceutical manufacturers have recently posed restrictions affecting Ryan White Clinics and other Safety Net Providers. RWC-340B has taken action to address these challenges head-on. On…
By letter dated March 21, 2021, Johnson & Johnson (J&J) announced that, effective May 2, 2022, it will no longer honor bill-to/ship-to orders for contract pharmacy arrangements with hospitals unless…
On September 30, U.S. Representative Matt Rosendale (R-MT) introduced the Drug Pricing Transparency and Accountability Act (H.R. 5463), which would amend the 340B statute to add a two-year moratorium on…
On September 23, U.S. Senator Mike Braun (R-IN) introduced a bill to amend the 340B statute to allow HHS to audit 340B covered entities to determine how they use “net…